Literature DB >> 15064035

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.

Ivan Casserly1, Eric Topol.   

Abstract

Late-onset sporadic Alzheimer's disease is a heterogeneous disorder. In elderly patients, increasing evidence suggests a link between this neurodegenerative disease, and vascular risk factors and atherosclerosis. The nature of this link remains speculative. Some investigators have suggested that the disease arises as a secondary event related to atherosclerosis of extracranial or intracranial vessels. A toxic effect of vascular factors on the microvasculature of susceptible brain regions has also been argued. An alternative explanation is that atherosclerosis and Alzheimer's disease are independent but convergent disease processes. This hypothesis is lent support by observations of shared epidemiology, pathophysiological elements, and response to treatment in both disorders. It provides a potential framework for an improved understanding of the pathogenesis of Alzheimer's disease, especially in elderly patients with vascular risk factors, and offers some promise toward the search for preventive and therapeutic treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064035     DOI: 10.1016/S0140-6736(04)15900-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  139 in total

1.  Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options.

Authors:  Hakon Hakonarson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Follow-up association study of linkage regions reveals multiple candidate genes for carotid plaque in Dominicans.

Authors:  Chuanhui Dong; Ashley Beecham; Liyong Wang; Susan H Blanton; Tatjana Rundek; Ralph L Sacco
Journal:  Atherosclerosis       Date:  2012-03-27       Impact factor: 5.162

3.  Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.

Authors:  Renã A S Robinson; Gururaj Joshi; Quanzhen Huang; Rukhsana Sultana; Austin S Baker; Jian Cai; William Pierce; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  Proteomics       Date:  2011-09-22       Impact factor: 3.984

4.  Potential beneficial effects of low molecular weight heparin on cognitive impairment in elderly patients on haemodialysis.

Authors:  Milenka Sain; Vedran Kovacic; Josipa Radic; Dragan Ljutic; Ivo Jelicic
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

Review 5.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 6.  Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes.

Authors:  Robert D Stout; Jill Suttles
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

7.  Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides.

Authors:  Laibaik Park; Ken Uekawa; Lidia Garcia-Bonilla; Kenzo Koizumi; Michelle Murphy; Rose Pistik; Linda Younkin; Steven Younkin; Ping Zhou; George Carlson; Josef Anrather; Costantino Iadecola
Journal:  Circ Res       Date:  2017-05-17       Impact factor: 17.367

8.  Individual differences in regional cortical volumes across the life span are associated with regional optical measures of arterial elasticity.

Authors:  Antonio M Chiarelli; Mark A Fletcher; Chin Hong Tan; Kathy A Low; Edward L Maclin; Benjamin Zimmerman; Tania Kong; Alexander Gorsuch; Gabriele Gratton; Monica Fabiani
Journal:  Neuroimage       Date:  2017-09-01       Impact factor: 6.556

9.  Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; John Farrell; Kathryn L Lunetta; Gyungah Jun; Clinton T Baldwin; Margaret M Deangelis; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

Review 10.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.